Cholinesterase
6 drugs CNS
2
approved indications
6
Approved Drugs
6
Companies
5
Indications
1
Therapeutic Areas
Top Drugs
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (6 companies)
✓ All 6 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (5 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
AZURITY 1 drug
Novartis 1 drug
EXELA PHARMA 1 drug
By Therapeutic Area
Other 5 drugs
CNS 1 drugs
Drugs by Company PRO
AZURITY 1 drug
Novartis 1 drug
EXELA PHARMA 1 drug
BAUSCH 1 drug
ALEMBIC PHARMS LTD 1 drug
AMPHASTAR PHARMS INC 1 drug
By Therapeutic Area
Other 5 drugs
PREVDUO, BLOXIVERZ, MESTINON, RIVASTIGMINE TARTRATE +1 more
CNS 1 drugs
EXELON
Indications Treated
Neuromuscular BlockadeMyasthenia GravisBradycardiaAlzheimer's DiseaseParkinson's Disease Dementia
All Drugs Targeting Cholinesterase
| Drug | Company | Approved | Indications | Therapeutic Area |
|---|---|---|---|---|
| PREVDUO | AZURITY | 2023 | 2 | |
| EXELON | Novartis | 2000 | 2 | CNS |
| BLOXIVERZ | EXELA PHARMA | 2013 | 1 | |
| MESTINON | BAUSCH | 1955 | 1 | |
| RIVASTIGMINE TARTRATE | ALEMBIC PHARMS LTD | 2007 | - | |
| NEOSTIGMINE METHYLSULFATE | AMPHASTAR PHARMS INC | 2015 | - |